Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malgorzata Mackiewicz-Wysocka

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Expert Opinion on Biological Therapy|June 25, 2002
3rd international symposium on genetic anticancer agentsPiotr J Wysocki, Malgorzata Mackiewicz-Wysocka
Expert Opinion on Biological Therapy|August 13, 2002
The 32nd Annual Meeting of German Society of Immunology. 26 - 29 September 2001Piotr J Wysocki, Malgorzata Mackiewicz-Wysocka
Expert Opinion on Investigational Drugs|April 17, 2012
Progress in the treatment of bone metastases in cancer patientsMalgorzata Mackiewicz-Wysocka, Magdalena Pankowska, Piotr J Wysocki
Expert Opinion on Investigational Drugs|December 11, 2012
New therapeutic options in systemic treatment of advanced cutaneous melanomaMalgorzata Mackiewicz-Wysocka, Jakub Zolnierek, Piotr J Wysocki
Diabetes Technology & Therapeutics|October 11, 2014
Skin pH is lower in type 1 diabetes subjects and is related to glycemic control of the diseaseMalgorzata Mackiewicz-Wysocka, Aleksandra Araszkiewicz, Pawel Niedzwiedzki, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Expert Opinion on Biological Therapy|June 25, 2002
3rd international symposium on genetic anticancer agentsPiotr J Wysocki, Malgorzata Mackiewicz-Wysocka
Expert Opinion on Biological Therapy|August 13, 2002
The 32nd Annual Meeting of German Society of Immunology. 26 - 29 September 2001Piotr J Wysocki, Malgorzata Mackiewicz-Wysocka
Expert Opinion on Investigational Drugs|April 17, 2012
Progress in the treatment of bone metastases in cancer patientsMalgorzata Mackiewicz-Wysocka, Magdalena Pankowska, Piotr J Wysocki
Expert Opinion on Investigational Drugs|December 11, 2012
New therapeutic options in systemic treatment of advanced cutaneous melanomaMalgorzata Mackiewicz-Wysocka, Jakub Zolnierek, Piotr J Wysocki
Diabetes Technology & Therapeutics|October 11, 2014
Skin pH is lower in type 1 diabetes subjects and is related to glycemic control of the diseaseMalgorzata Mackiewicz-Wysocka, Aleksandra Araszkiewicz, Pawel Niedzwiedzki, et al.
Pageof 1